Immune tolerance and the immune modulation protocol.
Berntorp
E
E
Department for Coagulation Disorders University Hospital, Malmö, Sweden.
Nilsson
I M
IM
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002985:Clinical Protocols; D003546:Cysteine Endopeptidases / Q000276:immunology / Q000627:therapeutic use*; D015949:Factor IXa / Q000276:immunology / Q000627:therapeutic use*; D015944:Factor VIIIa / Q000276:immunology / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology; D002836:Hemophilia B / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects*; D007163:Immunosorbent Techniques; D008875:Middle Aged; D009363:Neoplasm Proteins
D009363:Neoplasm Proteins; D015944:Factor VIIIa; D015949:Factor IXa; D003546:Cysteine Endopeptidases; C030910:cancer procoagulant